Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert Jordan

Showing results (131-140 of 149) with videos related to

Pageof 15
Sort By:
Antiviral Chemistry & Chemotherapy|October 28, 2022
Meeting report: 34th international conference on antiviral researchAndrea Brancale, Kara Carter, Leen Delang, et al.
Mbio|March 8, 2018
Coronavirus Susceptibility to the Antiviral Remdesivir (GS-5734) Is Mediated by the Viral Polymerase and the Proofreading ExoribonucleaseMaria L Agostini, Erica L Andres, Amy C Sims, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|March 24, 2023
A randomized controlled trial of presatovir for respiratory syncytial virus after lung transplantJens Gottlieb, Fernando Torres, Tarik Haddad, et al.
Antimicrobial Agents and Chemotherapy|February 14, 2013
Novel benzoxazole inhibitor of dengue virus replication that targets the NS3 helicaseChelsea M Byrd, Douglas W Grosenbach, Aklile Berhanu, et al.
Antiviral Research|July 5, 2025
Meeting report: 38th international conference on antiviral research in Las Vegas, United States of America, March 17-21, 2025Robert Jordan, Nancie M Archin, Valeria Cagno, et al.
Journal of Virology|September 29, 2005
An orally bioavailable antipoxvirus compound (ST-246) inhibits extracellular virus formation and protects mice from lethal orthopoxvirus ChallengeGuang Yang, Daniel C Pevear, Marc H Davies, et al.
Nature Communications|January 12, 2020
Comparative therapeutic efficacy of remdesivir and combination lopinavir, ritonavir, and interferon beta against MERS-CoVTimothy P Sheahan, Amy C Sims, Sarah R Leist, et al.
Plos One|August 23, 2011
Comparison of the safety and pharmacokinetics of ST-246® after i.v. infusion or oral administration in mice, rabbits and monkeysYali Chen, Adams Amantana, Shanthakumar R Tyavanagimatt, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 10, 2020
A Phase 2b, Randomized, Double-blind, Placebo-Controlled Multicenter Study Evaluating Antiviral Effects, Pharmacokinetics, Safety, and Tolerability of Presatovir in Hematopoietic Cell Transplant Recipients with Respiratory Syncytial Virus Infection of the Lower Respiratory TractFrancisco M Marty, Roy F Chemaly, Kathleen M Mullane, et al.
NPJ Vaccines|July 29, 2022
Mucosal administration of a live attenuated recombinant COVID-19 vaccine protects nonhuman primates from SARS-CoV-2Mariana F Tioni, Robert Jordan, Angie Silva Pena, et al.
Pageof 15

Showing results (131-140 of 149) with videos related to

Sort By:
Pageof 15
Antiviral Chemistry & Chemotherapy|October 28, 2022
Meeting report: 34th international conference on antiviral researchAndrea Brancale, Kara Carter, Leen Delang, et al.
Mbio|March 8, 2018
Coronavirus Susceptibility to the Antiviral Remdesivir (GS-5734) Is Mediated by the Viral Polymerase and the Proofreading ExoribonucleaseMaria L Agostini, Erica L Andres, Amy C Sims, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|March 24, 2023
A randomized controlled trial of presatovir for respiratory syncytial virus after lung transplantJens Gottlieb, Fernando Torres, Tarik Haddad, et al.
Antimicrobial Agents and Chemotherapy|February 14, 2013
Novel benzoxazole inhibitor of dengue virus replication that targets the NS3 helicaseChelsea M Byrd, Douglas W Grosenbach, Aklile Berhanu, et al.
Antiviral Research|July 5, 2025
Meeting report: 38th international conference on antiviral research in Las Vegas, United States of America, March 17-21, 2025Robert Jordan, Nancie M Archin, Valeria Cagno, et al.
Journal of Virology|September 29, 2005
An orally bioavailable antipoxvirus compound (ST-246) inhibits extracellular virus formation and protects mice from lethal orthopoxvirus ChallengeGuang Yang, Daniel C Pevear, Marc H Davies, et al.
Nature Communications|January 12, 2020
Comparative therapeutic efficacy of remdesivir and combination lopinavir, ritonavir, and interferon beta against MERS-CoVTimothy P Sheahan, Amy C Sims, Sarah R Leist, et al.
Plos One|August 23, 2011
Comparison of the safety and pharmacokinetics of ST-246® after i.v. infusion or oral administration in mice, rabbits and monkeysYali Chen, Adams Amantana, Shanthakumar R Tyavanagimatt, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 10, 2020
A Phase 2b, Randomized, Double-blind, Placebo-Controlled Multicenter Study Evaluating Antiviral Effects, Pharmacokinetics, Safety, and Tolerability of Presatovir in Hematopoietic Cell Transplant Recipients with Respiratory Syncytial Virus Infection of the Lower Respiratory TractFrancisco M Marty, Roy F Chemaly, Kathleen M Mullane, et al.
NPJ Vaccines|July 29, 2022
Mucosal administration of a live attenuated recombinant COVID-19 vaccine protects nonhuman primates from SARS-CoV-2Mariana F Tioni, Robert Jordan, Angie Silva Pena, et al.
Pageof 15